• Home
  • Search Results
  • Optimization and pharmacological characterization of a refined cisplatin-induced rat model of peripheral neuropathic pain.

Optimization and pharmacological characterization of a refined cisplatin-induced rat model of peripheral neuropathic pain.

Behavioural pharmacology (2014-10-18)
Felicity Yaqin Han, Bruce D Wyse, Maree T Smith
ABSTRACT

Chemotherapy-induced peripheral neuropathy (CIPN) is the major dose-limiting side-effect of many front-line anticancer drugs. This study was designed to establish and pharmacologically characterize a refined rat model of cisplatin-induced CIPN. Adult male Sprague-Dawley rats received four (n=18) or five (n=18) single intraperitoneal bolus doses of cisplatin at 3 mg/kg, or saline (control group), once-weekly. Body weight and general health were assessed over a 49-day study period. von Frey filaments and the Hargreaves test were used to define the time course for the development of mechanical allodynia and thermal hypoalgesia in the hindpaws and for efficacy assessment of analgesic/adjuvant agents. The general health of rats administered four cisplatin doses was superior to that of rats administered five doses. Mechanical allodynia was fully developed (paw withdrawal thresholds≤6 g) in the bilateral hindpaws from day 32 to 49 for both cisplatin dosing regimens. They also showed significant thermal hypoalgesia in the bilateral hindpaws. In cisplatin-treated rats with paw withdrawal thresholds of up to 6 g, single bolus doses of gabapentin and morphine produced dose-dependent analgesia, whereas meloxicam and amitriptyline lacked efficacy. We have established and pharmacologically characterized a refined rat model of CIPN that is suitable for efficacy profiling of compounds from analgesic discovery programmes.

MATERIALS
Product Number
Brand
Product Description

Pure Water Density Standard, UKAS ISO/IEC17025 and ISO Guide 34 certified, density: 0.9982 g/mL at 20 °C, density: 0.9970 g/mL at 25 °C
Pure Water Density Standard, UKAS ISO/IEC17025 and ISO Guide 34 certified, density: 0.9982 g/mL at 20 °C, density: 0.9970 g/mL at 25 °C
Sigma-Aldrich
Water, HPLC Plus
Sigma-Aldrich
Water, suitable for HPLC
Sigma-Aldrich
Water, deionized
Sigma-Aldrich
Water, ACS reagent
Supelco
Amitriptyline hydrochloride, Pharmaceutical Secondary Standard; Certified Reference Material
Amitriptyline hydrochloride, European Pharmacopoeia (EP) Reference Standard
Sigma-Aldrich
Amitriptyline hydrochloride, ≥98% (TLC), powder
Sigma-Aldrich
Water, sterile-filtered, BioReagent, suitable for cell culture
Sigma-Aldrich
Water, for embryo transfer, sterile-filtered, BioXtra, suitable for mouse embryo cell culture
Sigma-Aldrich
Water, PCR Reagent
Sigma-Aldrich
E-Toxate Water, endotoxin, free
Sigma-Aldrich
Water, Nuclease-Free Water, for Molecular Biology
Sigma-Aldrich
Water, for molecular biology, sterile filtered
Sigma-Aldrich
Water, tested according to Ph. Eur.
Supelco
Water, for HPCE, for luminescence, suitable for UV/Vis spectroscopy
Sigma-Aldrich
Water, for cell biology, sterile ultrafiltered
Supelco
Water, ACS reagent, for ultratrace analysis
Supelco
Water, suitable for ion chromatography
Sigma-Aldrich
Water, BioPerformance Certified
Supelco
Density Standard 998 kg/m3, H&D Fitzgerald Ltd. Quality
Sigma-Aldrich
Water, deuterium-depleted, ≤1 ppm (Deuterium oxide)
USP
Amitriptyline hydrochloride, United States Pharmacopeia (USP) Reference Standard
Supelco
Water, for TOC analysis
Sigma-Aldrich
Water-16O, ≥99.94 atom % 16O